During the past decade, Universitätsfrauenklinik Ulm conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsfrauenklinik Ulm" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "AGO Study Group" with 4 trials sponsored, "AGO Research GmbH" with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Swiss Group for Clinical Cancer Research" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsfrauenklinik Ulm" #1 collaborator was "ARCAGY/ GINECO GROUP" with 3 trials as a collaborator, "German Breast Group" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsfrauenklinik Ulm" are "Breast Cancer" (7 trials), "Ovarian Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Endometrial Cancer" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Universitätsfrauenklinik Ulm" in a lesser frequency.

Most popular intervention types in "Universitätsfrauenklinik Ulm" are "Drug" (25 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Carboplatin" (6 trials), "Placebo" (6 trials), "Atezolizumab" (4 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsfrauenklinik Ulm" are 21 trials for "Female" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsfrauenklinik Ulm". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Universitätsfrauenklinik Ulm, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsfrauenklinik Ulm, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".